Vessel co-option in cancer

Nature Reviews. Clinical Oncology
Elizabeth A KuczynskiAndrew R Reynolds

Abstract

All solid tumours require a vascular supply in order to progress. Although the ability to induce angiogenesis (new blood vessel growth) has long been regarded as essential to this purpose, thus far, anti-angiogenic therapies have shown only modest efficacy in patients. Importantly, overshadowed by the literature on tumour angiogenesis is a long-standing, but continually emerging, body of research indicating that tumours can grow instead by hijacking pre-existing blood vessels of the surrounding nonmalignant tissue. This process, termed vessel co-option, is a frequently overlooked mechanism of tumour vascularization that can influence disease progression, metastasis and response to treatment. In this Review, we describe the evidence that tumours located at numerous anatomical sites can exploit vessel co-option. We also discuss the proposed molecular mechanisms involved and the multifaceted implications of vessel co-option for patient outcomes.

References

Oct 1, 1978·Journal of the History of Medicine and Allied Sciences
Jan 3, 1991·The New England Journal of Medicine·N WeidnerJ Folkman
May 1, 1990·The American Journal of Surgical Pathology·P PääkköH Autio-Harmainen
Jan 1, 1989·Virchows Archiv. A, Pathological Anatomy and Histopathology·A BugajskiA J Miodoński
Jun 15, 1989·Biochemical and Biophysical Research Communications·N Ferrara, W J Henzel
May 1, 1985·Acta Pathologica Japonica·S SugiharaT Nakashima
Oct 1, 1988·Human Pathology·A Kolin, T Koutoulakis
Aug 12, 1971·The New England Journal of Medicine·J Folkman
Oct 1, 1967·Cancer·E N MilneJ T Stoughton
Aug 1, 1967·Diseases of the Chest·M B RosenblattF Collier
Oct 1, 1994·Pathology International·M KinK Tanikawa
Jul 1, 1995·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·O NakashimaM Kojiro
Feb 1, 1996·Japanese Journal of Clinical Oncology·N TerayamaY Nakanuma
Jun 1, 1996·Nature Medicine·M S O'ReillyJ Folkman
Dec 1, 1996·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·F PezzellaA L Harris
Aug 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·U PastorinoF Rilke
Jul 10, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·R YamaguchiM Kojiro
Sep 17, 1999·The American Journal of Pathology·A J ManiotisM J Hendrix
Jan 5, 2000·The Annals of Thoracic Surgery·M HigashiyamaK Kuriyama
Jul 26, 2000·Diseases of the Colon and Rectum·P GervazS Wexner
Aug 19, 2000·Science·B St CroixK W Kinzler
Sep 27, 2000·Neoplasia : an International Journal for Oncology Research·J L RubensteinM A Shuman
Apr 13, 2001·Cancer·B V OffersenJ Overgaard
Jun 26, 2001·Histopathology·K N NareshA M Borges
Jul 21, 2001·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·A CarrettaP Zannini
Mar 1, 2002·British Journal of Cancer·E PassalidouF Pezzella
Jul 13, 2002·The Journal of Pathology·Balázs DömeJózsef Tímár
Aug 15, 2002·Proceedings of the National Academy of Sciences of the United States of America·Eugene S KimDarrell J Yamashiro
Aug 31, 2002·Endothelium : Journal of Endothelial Cell Research·William P J LeendersRobert M W de Waal

❮ Previous
Next ❯

Citations

Jul 10, 2019·The FEBS Journal·Kabir A KhanRoy Bicknell
Oct 1, 2019·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Usman ArshadAndrew Owen
Jan 16, 2020·International Journal of Molecular Sciences·Anubhab MukherjeeSudip Mukherjee
Oct 20, 2019·Angiogenesis·Yu ZhangAndrew C Dudley
Jan 31, 2020·International Immunology·Hisamichi NaitoNobuyuki Takakura
Feb 23, 2020·International Journal of Cancer. Journal International Du Cancer·Lino MöhrmannSebastian M Dieter
Apr 18, 2020·EMBO Molecular Medicine·Mahak SinghalHellmut G Augustin
Nov 30, 2019·Nature Reviews. Cancer·Adrienne BoireManuel Valiente
Nov 7, 2019·Cellular and Molecular Life Sciences : CMLS·Roberta LuganoAnna Dimberg
Feb 26, 2020·Nature Reviews. Immunology·Sirpa Jalkanen, Marko Salmi
Mar 31, 2020·International Journal of Cancer. Journal International Du Cancer·Marine JaryJean P Feugeas
Jun 28, 2020·Journal for Immunotherapy of Cancer·Sandra García-MuleroRebeca Sanz-Pamplona
Jul 15, 2020·Cells·María Auxiliadora Olivares-UrbanoMaría Isabel Núñez
Aug 23, 2020·International Journal of Molecular Sciences·Wioletta OlejarzTomasz Lorenc
Aug 25, 2020·Circulation Research·Guy EelenPeter Carmeliet
Dec 23, 2019·Angiogenesis·Elizabeth A Kuczynski, Andrew R Reynolds
Jan 21, 2020·Journal of Cellular and Molecular Medicine·Zeru FengXikun Zhou
Aug 10, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Thomas MuellerHans-Joachim Schmoll
Aug 11, 2020·Frontiers in Cell and Developmental Biology·Christopher Montemagno, Gilles Pagès
Oct 28, 2019·Angiogenesis·Emily LataczPeter B Vermeulen
Sep 19, 2020·Cancer Cell International·Ying Shao, Bingjian Lu
Sep 17, 2020·Oncotarget·Mariana PerepitchkaVasiliy Galat
Mar 19, 2020·Cell Communication and Signaling : CCS·Ji-Yan XieJun Min
Oct 11, 2020·International Journal of Molecular Sciences·Maria PeleliAndreas Papapetropoulos
Dec 2, 2020·Journal for Immunotherapy of Cancer·Louis LantierIsabelle Dimier-Poisson
Dec 10, 2020·Cancer Reports·Francesco Pezzella, Domenico Ribatti
Oct 16, 2020·International Journal of Pharmaceutics·Yu-Cheng ZhouPei-Yang Hu
Dec 25, 2019·Molecular Therapy Oncolytics·Meijun ZhengHui Yang
Jan 24, 2021·Expert Opinion on Therapeutic Targets·Hans-Georg WirschingMichael Weller
Dec 31, 2019·Seminars in Cancer Biology·Thomas Efferth, Franz Oesch
Dec 5, 2020·Antibodies·Maciej M MarkiewskiMagdalena Karbowniczek
Dec 3, 2020·Frontiers in Immunology·Gizem DuruNiels Heemskerk
Feb 16, 2021·ACS Biomaterials Science & Engineering·Seunggyu KimJessie S Jeon
Feb 16, 2021·Journal of Cellular and Molecular Medicine·Shuqiong ZhangLisong Shen
Dec 3, 2020·Molecular Cancer Research : MCR·Nikunj GevariyaVincent Fradet

❮ Previous
Next ❯

Methods Mentioned

BETA
xenograft
xenografts
biopsy
imaging techniques

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.